If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
276.60    3.80 (1.39%)
Bid:
276.00
Ask:
276.60
Spread: 0.60 (0.217%)
Market Cap: £697.24m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

7 May 2021 17:23

RNS Number : 9888X
Genuit Group PLC
07 May 2021
 

Genuit Group plc (the "Company")

 

Notification of transactions by Person Discharging Managerial Responsibilities

 

The Company announces that on 4 May 2021, Glen Sabin, Chief Operating Officer and a Person Discharging Managerial Responsibilities, exercised the following options:

 

1. a nil-cost option over 18,376 shares in accordance with the Long Term Incentive Plan Award granted to him on 2 May 2018. Mr. Sabin sold all exercised shares with the appropriate tax and national insurance liabilities deducted from the sale proceeds.

 

2. a nil-cost option over a total of 1,537 shares (comprising 1,482 shares granted under the Award and 55 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 2 May 2018. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

3. a nil-cost option over a total of 4,141 shares (comprising 4,027 shares granted under the Award and 114 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 30 April 2019. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

Mr. Sabin now holds an interest in a total of 716,574 shares.

 

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

 

 

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Sale of Shares acquired for no consideration pursuant to the exercise of nil-cost options in accordance with the Long Term Incentive Plan ("LTIP") award granted on 2 May 2018.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£5.68

18,376

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

18,376

 

 

£5.68

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options as follows: Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018.

Deferred Share Bonus Plan ("DSBP") award granted on 30 April 2019.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

Nil

818 - Number of DSBP shares acquired from

2 May 2018 grant after reduction for appropriate tax and national insurance liabilities.

 

 

 

 

 

 

2,204 - Number of DSBP shares acquired from 30 April 2019 grant after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

N/A

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

Enquiries:

 

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKOBBABKDDPK
Date   Source Headline
17th Mar 202311:28 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
8th Mar 20234:26 pmRNSBoard updates
28th Feb 20235:55 pmRNSHolding(s) in Company
27th Feb 20239:36 amRNSDirectorate Change
31st Jan 202310:22 amRNSDirector Declaration
26th Jan 20236:27 pmRNSHolding(s) in Company
28th Nov 20224:05 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSCapital Markets Day Notification
15th Nov 20228:36 amRNSDirector Declaration
11th Nov 20224:47 pmRNSHolding(s) in Company
9th Nov 20223:34 pmRNSDirector/PDMR Shareholding
8th Nov 202212:27 pmRNSHolding(s) in Company
4th Nov 202210:56 amRNSHolding(s) in Company
3rd Nov 20224:21 pmRNSDirector/PDMR Shareholding
1st Nov 20229:51 amRNSBlock listing Interim Review
28th Oct 20222:59 pmRNSHolding(s) in Company
27th Oct 202212:41 pmRNSCapital Markets Day Notification-Date rescheduled
25th Oct 20227:00 amRNSTrading Update
18th Oct 20224:28 pmRNSDirectorate Change
21st Sep 20223:44 pmRNSHolding(s) in Company
14th Sep 20227:00 amRNSCapital Markets Day Notification
12th Sep 202212:33 pmRNSDirector/PDMR Shareholding
7th Sep 20222:24 pmRNSDirector/PDMR Shareholding
6th Sep 20225:29 pmRNSHolding(s) in Company
5th Sep 202210:53 amRNSDirector/PDMR Shareholding
2nd Sep 20223:53 pmRNSDirectorate Change
2nd Sep 20222:01 pmRNSHolding(s) in Company
26th Aug 202211:50 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSHalf-year Report
11th Aug 202212:50 pmRNSHolding(s) in Company
3rd Aug 20229:32 amRNSHolding(s) in Company
28th Jul 20223:59 pmRNSHolding(s) in Company
26th Jul 20224:04 pmRNSHolding(s) in Company
18th Jul 20229:25 amRNSHolding(s) in Company
7th Jul 20223:52 pmRNSHolding(s) in Company
27th Jun 20224:38 pmRNSHolding(s) in Company
24th Jun 20224:00 pmRNSDirector/PDMR Shareholding
17th Jun 20224:02 pmRNSHolding(s) in Company
15th Jun 20224:36 pmRNSHolding(s) in Company
13th Jun 20224:26 pmRNSDirector/PDMR Shareholding
31st May 202210:00 amRNSTotal Voting Rights
19th May 202211:33 amRNSResult of AGM
19th May 20227:00 amRNSTrading update
12th May 20224:00 pmRNSHolding(s) in Company
9th May 20223:41 pmRNSHolding(s) in Company
3rd May 20223:02 pmRNSBlock listing Interim Review
3rd May 20222:31 pmRNSDirector/PDMR Shareholding
3rd May 20222:25 pmRNSDirector/PDMR Shareholding
29th Apr 20221:09 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.